Adverse events should be reported.
Healthcare professionals are asked to report any suspected adverse events via:
HPRA Pharmacovigilance
Tel: | +353 1 6764971 |
Fax: | +353 1 6762517 |
Website: | |
Email: |
Medicinal products displaying the black triangle symbol ▼ are subject to additional monitoring and it is therefore important to report any suspected adverse events related to this medicinal product.
Adverse events should also be reported to Janssen-Cilag Ltd on 0044 1494 567447 or at dsafety@its.jnj.com.
CP-442378 - March 2024